Lauri Neyer

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

Daniel Wynn, Michael D. Kaufman, Xavier Montalbán et al. · The Lancet Neurology · 2010 · 300 citations

Life Sciences, Neurology, Pharmacotherapy +10

IL-10 Is Required for Prevention of Necrosis in the Small Intestine and Mortality in Both Genetically Resistant BALB/c and Susceptible C57BL/6 Mice Following Peroral Infection with <i>Toxoplasma gondii</i>

Yasuhiro Suzuki, Alan Sher, George Yap et al. · The Journal of Immunology · 2000 · 221 citations · Full text

Veterinary Medicine, Immunology, Pathology +17

Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii

Lauri Neyer, Gabriele Grünig, Madeline Fort et al. · Infection and Immunity · 1997 · 201 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo

Armen B. Shanafelt, Yue Lin, Marie-Claude Shanafelt et al. · Nature Biotechnology · 2000 · 133 citations

Life Sciences, Immunology, Oncology +14

Type I interferons enhance production of IFN-γ by NK cells

Christopher A. Hunter, Katie E. Gabriel, Thad Radzanowski et al. · Immunology Letters · 1997 · 100 citations · Full text

Life Sciences, Immunology, Immunology Of Infectious Diseases +16